Equity Transaction Chart
Viridian publishes weekly data on equity capital raises in the Cannabis/CBD/Psychedelic industries. This data includes information about the company issuing equity (public/private, state/country location), deal size, deal structure, pricing, share information, deal implied valuation, and warrant information.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
This Section is Only Available to Higher Tier Memberships
Please Purchase a Premium or Enterprise membership to see more.
Equity Commentary
Equity Raises:
-
- On May 16, 2025, MindBio Therapeutics. (MBIO: CSE), a clinical-stage biopharmaceutical company focused on developing novel psychedelic-based medicines for mental health disorders, closed a non-brokered private placement for gross proceeds of $92,920.
- The company sold 9.28 million shares, representing a 1.7% increase in total shares outstanding, at a discount of 28% to the pre-announcement price.
- Proceeds will be used to fund working capital and other general corporate purposes.
- The transaction implies a market cap of $3.99M and an EV of $6.98M
- The company also announced a debt settlement in which an aggregate of $1.9 million of unsecured notes and payables were exchanged for 183.9 million shares.
Public vs. Private Raises:
- The only capital raiser of the week was a public company that trades on the CSE.
Equity vs. Debt Cap Raises:
- Debt accounted for 67% of trailing 8-week capital raises. The ratio may go down if companies are able to utilize favorable regulatory-induced stock price increases to complete equity issues. However, equity pricing has remained stubbornly low while the cannabis debt capital markets have reopened.
Viridian publishes weekly insights on equity capital raises in the Cannabis/CBD/Psychedelic industries. These insights typically highlight the most interesting/meaningful equity transactions of that week, and commentary on market conditions, equity deal structures and investor groups.